D2-40 (podoplanin) has been reported to highlight not only a variety of vascular tumors but is a useful tool in distinguishing PAC and other cutaneous tumors from metastatic adenocarcinoma to the skin. The gene discussed is PDPN; the disease is vascular neoplasm.